C-9 alkenylidine bridged macrolides

Details C-9 alkenylidine bridged macrolides C-9 alkenylidine bridged macrolides

2007-11-15

2009-11-24

Peselev, Elli (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S007200, C536S007300, C536S007400

Reexamination Certificate

active

07622452

ABSTRACT:
The present invention discloses compounds of formulae (I), (II) or pharmaceutically acceptable salts, esters, or prodrugs thereof:which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.

REFERENCES:
patent: 6590083 (2003-07-01), Hlasta et al.
patent: 6878691 (2005-04-01), Or et al.
patent: 7229972 (2007-06-01), Or et al.
patent: 2006/0122128 (2006-06-01), Or et al.
patent: 2006/0252710 (2006-11-01), Wang et al.
patent: WO/2006/047167 (2006-05-01), None

Affiliated with

Also associated with

Rating

C-9 alkenylidine bridged macrolides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with C-9 alkenylidine bridged macrolides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-9 alkenylidine bridged macrolides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4092618